Allopurinol, a drug normally prescribed for gout, is being used to test for
tumours in patients at high risk of developing cancer due to genetic or
environmental factors. Developed by researchers at Johns Hopkins University in
Baltimore, Maryland, the test uses allopurinol to temporarily slow DNA
production in cancer cells, causing some components of DNA—called
pyrimidines—to accumulate in the blood. These can be detected in the
patient’s urine.
More from 51¶¯Âþ
Explore the latest news, articles and features
Popular articles
Trending 51¶¯Âþ articles
1
Mathematicians stunned by AI's biggest breakthrough in mathematics yet
2
Photos reveal unexpected details from the world's first atomic test
3
The Selfish Gene at 50: Why Dawkins’s evolution classic still holds up
4
We may finally know why dinosaurs like T. rex evolved tiny arms
5
How I used psychology to come back from the worst year of my life
6
The distant world that is our best hope of finding alien life
7
The ‘doomsday’ glacier’s giant ice shelf is about to break away
8
Epic dreaming is leaving people exhausted and distressed
9
Extreme heat hampers children’s early learning
10
CAR T-cell therapy bolstered by stiffening up cancer cells first
